(Q34548972)

3 August 2017

title

Highly active antiretroviral therapy and viral response in HIV type 2 infection (English)

1 reference

3 August 2017

main subject

anti-retroviral agent

0 references

14

Phyllis J Kanki

1 reference

3 August 2017

Christopher Mullins

1

1 reference

3 August 2017

Geoffrey Eisen

2

1 reference

3 August 2017

Stephen Popper

3

1 reference

3 August 2017

Abdoulaye Dieng Sarr

4

1 reference

3 August 2017

Jean-Louis Sankale

5

1 reference

3 August 2017

Judith J Berger

6

1 reference

3 August 2017

Sharon B Wright

7

1 reference

3 August 2017

Hernan R Chang

8

1 reference

3 August 2017

Gerard Coste

9

1 reference

3 August 2017

Timothy P Cooley

10

1 reference

3 August 2017

Peter Rice

11

1 reference

3 August 2017

Paul R Skolnik

12

1 reference

3 August 2017

Margaret Sullivan

13

1 reference

3 August 2017

language of work or name

English

0 references

publication date

25 May 2004

1 reference

Clinical Infectious Diseases

3 August 2017

published in

1 reference

3 August 2017

volume

38

1 reference

3 August 2017

issue

12

1 reference

3 August 2017

page(s)

1771-1779

1 reference

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa

3 August 2017

cites work

1 reference

Isolation of a new human retrovirus from West African patients with AIDS.

21 January 2018

1 reference

New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

21 January 2018

1 reference

The spread of human immunodeficiency virus type 2 into Europe: a geographical analysis

21 January 2018

1 reference

The global distribution of human immunodeficiency virus type 2 (HIV-2) infection

21 January 2018

1 reference

Slower heterosexual spread of HIV-2 than HIV-1.

21 January 2018

1 reference

Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast

21 January 2018

1 reference

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

21 January 2018

1 reference

HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts.

21 January 2018

1 reference

Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.

21 January 2018

1 reference

Antibodies to the HIV type 2 core protein p26 and Vpx: association with disease progression.

21 January 2018

1 reference

Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose

21 January 2018

1 reference

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives

21 January 2018

1 reference

Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors

21 January 2018

1 reference

Comparison of the sensitivities of primary isolates of HIV type 2 and HIV type 1 to antiviral drugs and drug combinations

21 January 2018

1 reference

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

21 January 2018

1 reference

Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides

21 January 2018

1 reference

Strategies for antiviral therapy in AIDS.

21 January 2018

1 reference

Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro

21 January 2018

1 reference

Analysis of HIV-2 RT mutants provides evidence that resistance of HIV-1 RT and HIV-2 RT to nucleoside analogs involves a repositioning of the template-primer

21 January 2018

1 reference

Potency comparison of peptidomimetic inhibitors against HIV-1 and HIV-2 proteinases: design of equipotent lead compounds

21 January 2018

1 reference

Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/421390

1 reference

3 August 2017

1 reference